Literature DB >> 6445239

Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain.

R R Vunnam, N S Radin.   

Abstract

In a search for potent inhibitors of glucocerebroside biosynthesis, we synthesized aromatic analogs of the enzyme's substrate, ceramide, many of which have not previously been described in the literature. Mouse brain and spleen, rat brain, and human placenta and spleen were all found to be susceptible to inhibition by a variety of compounds, although to differing extents. The most potent inhibitor was 2-decanoylamino-3-morpholino-1-phenylpropanol. The dehydro version of this compound (2-decanoylamino-3-morpholinopropiophenone) was less effective but it produced inactivation of the enzyme, probably by covalent reaction with the enzyme's active site. Examination of the various effects seen leads us to suggest that the active region of the enzyme contains four recognitional sites: an anionic moiety that may bind the glucose in activated form, an oxygen-binding region oriented toward the third carbon atom of ceramide, a narrow region that binds the alkyl chain of the fatty acid moiety, and a less narrow region that binds the hydrocarbon chain of the sphingoid base moiety.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445239     DOI: 10.1016/0009-3084(80)90057-2

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  34 in total

Review 1.  Group XV phospholipase A₂, a lysosomal phospholipase A₂.

Authors:  James A Shayman; Robert Kelly; Jessica Kollmeyer; Yongqun He; Akira Abe
Journal:  Prog Lipid Res       Date:  2010-11-11       Impact factor: 16.195

2.  In memoriam: Norman S. Radin (1920-2013).

Authors:  James A Shayman
Journal:  J Lipid Res       Date:  2013-07       Impact factor: 5.922

3.  Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.

Authors:  Marimuthu Subathra; Midhun Korrapati; Lauren A Howell; John M Arthur; James A Shayman; Rick G Schnellmann; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

4.  Fungal allergen β-glucans trigger p38 mitogen-activated protein kinase-mediated IL-6 translation in lung epithelial cells.

Authors:  Wendy A Neveu; Edgar Bernardo; Jenna L Allard; Viswas Nagaleekar; Matthew J Wargo; Roger J Davis; Yoichiro Iwakura; Laurie A Whittaker; Mercedes Rincon
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-03       Impact factor: 6.914

Review 5.  Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology.

Authors:  Tracey M Gloster; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2012-07-18       Impact factor: 15.040

6.  A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

Authors:  Elena Lukina; Nora Watman; Elsa Avila Arreguin; Maryam Banikazemi; Marta Dragosky; Marcelo Iastrebner; Hanna Rosenbaum; Mici Phillips; Gregory M Pastores; Daniel I Rosenthal; Mathilde Kaper; Tejdip Singh; Ana Cristina Puga; Peter L Bonate; M Judith Peterschmitt
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

Review 7.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

8.  Histidine-193 of rat glucosylceramide synthase resides in a UDP-glucose- and inhibitor (D-threo-1-phenyl-2-decanoylamino-3-morpholinopropan-1-ol)-binding region: a biochemical and mutational study.

Authors:  K Wu; D L Marks; R Watanabe; P Paul; N Rajan; R E Pagano
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

9.  E-selectin receptors on human leukocytes.

Authors:  Leonardo Nimrichter; Monica M Burdick; Kazuhiro Aoki; Wouter Laroy; Mark A Fierro; Sherry A Hudson; Christopher E Von Seggern; Robert J Cotter; Bruce S Bochner; Michael Tiemeyer; Konstantinos Konstantopoulos; Ronald L Schnaar
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

Review 10.  The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity?

Authors:  James A Shayman
Journal:  Trans Am Clin Climatol Assoc       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.